纵横研报
Ticker Detail

600488.SHG

¥6.98+7.88% 津药药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Tianjin Tianyao Pharmaceuticals Co Ltd
医疗健康 · 专科与仿制药

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, betamethasone product series, and other hormone precursors. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It also exports its products to the United States, Southeast Asia, Asia, Europe, South America, Africa, and internationally. The company was founded in 1939 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.

MARKET 市值 6.09B CNY PE 186.0x Fwd 31.9x 52W ¥3.68 – ¥8.44 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -22.6% ROE 1.6% 营业利润率 8.7% 净利润率 1.0%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制